About Biogenity

We take great pride in guiding you from sample to biology, tying it all together with our easy-to-follow reports and powerful tools for interpretation. Our mission is to assist omics discovery by empowering researchers, like you, with our expertise to get the most out of the omics analysis. Our vision is to advance omics research and bring better healthcare to future generations.

Latest news from Biogenity

We are hiring an Omics Scientist/Customer Consultant

August 7, 2025 | By Louis Loeb

We are seeking a new colleague to join us in supporting scientists from various industries, including pharmaceutical, biotech, food technology, and academia, in their omics research projects. We are looking for a highly skilled and motivated individual with a passion for Omics and customer consulting. The role requires you have experience within at least one of following areas: transcriptomics, metabolomes or proteomics. This includes knowledge of sample requirements, different approaches to sample analysis, and hands-on experience with data interpretation and analysis. You also need to be experienced R user, as the work include execution, optimization and development of analytical pipelines in R or python.


Read the job advert More news

Meet the team

Kenneth K.
Kenneth Kastaniegaard, Ph.D.

Protein and applied AI expert

CEO & Co-founder
Louis L.
Louis Loeb, M.Sc.

Marketing and UX domain expert

CCO & Co-founder
Rune
Rune Larsen, Ph.D.

Scientist and omics expert

Biomedical Engineer
Anezka
Anežka B. Forero, Ph.D. Fellow

Scientist and omics consultant

Biomedical Engineer

Meet the Board of Advisors

Kim B.
Kim Budolph Johansen

Managing Director, Executive Coach & Leadership Advisor at Budolph ApS
Jesper K.
Jesper Kihl

Senior Advisor.
Former Vice President in Regulatory Affairs at LEO Pharma & Novo Nordisk
Peter Birk
Peter Birk

Partner at Accelerace Management A/S

Other R&D developments

Mapping exposure-induced immune effects

Biogenity is part of EXPOSIM, an EU project that investigates environmental stressors as causal determinants for immune-mediated diseases. The project maps and prioritises evidence on how environmental stressors affect immune health, creating a strong evidence base for knowledge-based policy-making. Our role focuses on developing neural networks to identify potential causal links between exposures and immune-related diseases using the DOC#X database.

Biogenity also contributed to the recently concluded EXIMIOUS project, which pioneered new ways of assessing the human exposome and its association with immune-mediated diseases. EXPOSIM builds directly on EXIMIOUS, and we continue this work by carrying forward the methods and insights we helped develop into EXPOSIM.

Horizon Europe projects

EXIMIOUS & EXPOSIM

Corporate social responsibility

Plant a tree with Biogenity

Biogenity donates a dozen trees for every project delivered to support local communities, reforestation in the Amazon rainforest, and reducing CO2 emissions.

Partnering with One Tree Planted, we want to work towards a brighter future with better treatment for diseases and a healthy planet to enjoy life. For us, our children, grandchildren, and the generations to come.


Plant a tree